Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN.
Saved in:
| Title: | Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT-MAINTAIN. |
|---|---|
| Authors: | Horn DB; University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston, Texas, USA., Aronne LJ; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, New York, USA., Wharton S; University of Toronto and Wharton Weight Management Clinic, Toronto, Ontario, Canada., Bays HE; Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, USA., Gomez-Valderas E; Eli Lilly and Company, Indianapolis, Indiana, USA., Arad AD; Eli Lilly and Company, Indianapolis, Indiana, USA., Sharma P; Eli Lilly and Company, Indianapolis, Indiana, USA., Dunn JP; Eli Lilly and Company, Indianapolis, Indiana, USA., Senyucel C; Eli Lilly and Company, Indianapolis, Indiana, USA., Lee CJ; Eli Lilly and Company, Indianapolis, Indiana, USA. |
| Source: | Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2025 Oct; Vol. 33 (10), pp. 1873-1885. Date of Electronic Publication: 2025 Sep 07. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1930-739X (Electronic) Linking ISSN: 19307381 NLM ISO Abbreviation: Obesity (Silver Spring) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
